Briefing Summary: US FDA Posts Advisory Committee Materials for Review of Potential Risks With Gadolinium-Based Contrast Agents Report
Briefing Summary: US FDA Posts Advisory Committee Materials for Review of Potential Risks With Gadolinium-Based Contrast Agents Report